ArticleJournal of thoracic disease2025
Feasibility and safety of outside the cage subcostal robotic anatomical lung resections: results of a phase I clinical trial.
Article in Journal of thoracic disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05832112 (Outside the Cage), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Outside the Cage (OTC) Robotic Lobectomy, Single Center Human Phase I Trial
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The utilization of robotic-assisted thoracic surgery (RATS) for lung resections is increasing worldwide due to its minimally invasive footprint and relative ease compared to other approaches. However, current standard approaches to lobectomy using multiport robotic platforms involve trocar placement through the intercostal space(s), with resulting postoperative pain-related complications and the potential for chronic pain. In order to avoid instrumentation between the ribs and potential damage to the intercostal nerve bundle(s), we developed a non-intercostal, outside the thoracic cage (OTC) approach for RATS anatomical pulmonary resections. In this study we evaluated the safety, feasibility and postoperative outcomes associated with this technique. Methods: The study consisted of a prospective phase 1 clinical trial (NCT05832112) to evaluate safety and feasibility of the OTC technique. Patients planned to undergo minimally invasive lobectomy for resectable lung cancer were prospectively enrolled. Conversion rate and 30-day mortality were the primary outcome measures. Results: A total of 20 cases were analyzed. There were no conversions. There was no mortality at 30 days which represent respectively, the feasibility and safety primary outcome measures in this study. The median age of the patients was 63 [33-79] years, with a mean body mass index (BMI) of 28.6 [21.16-44.12] kg/m Conclusions: The RATS OTC technique for anatomic pulmonary resection was feasible and safe for patients with resectable non-small cell lung cancer (NSCLC) planned to undergo minimally invasive surgery (MIS) lobectomy in our center. Comparative and multi-center studies are needed to further assess the benefits, generalizability, and actual clinical relevance of this novel surgical approach.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.